Exosens Stock Rises 2.75% at Close, Driven by Defense Sector Momentum
Exosens stock closed the trading session on Tuesday, December 30, 2025, at 48.50 euros, marking a 2.75% increase from the previous day's close of 47.20 euros. The stock fluctuated within a narrow range from 47 euros at the opening to 48.50 euros during the session, with limited trading volumes of only 0.1% of the capital exchanged. This upward movement allows the defense optronics specialist to continue its positive momentum over the week, showing a performance of 3.08%, while over three months, the increase reaches 10.23%.
On a technical level, the stock is now trading above its 50-day moving average, set at 45.79 euros, confirming the resumption of an upward trend after a few sessions of consolidation. The resistance at 48.90 euros, close to the closing price of the day, constitutes the immediate next target for investors. With an RSI at 57, the stock remains in a neutral zone, avoiding any speculative excess.
Historical Performance and Strategic Announcements
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Since its IPO in June 2024, Exosens has shown a spectacular performance of 148.8% over one year, driven by a series of strategic announcements. The company secured the largest contract ever in the history of night vision technology, incorporating 200,000 16 mm tubes worth more than 500 million euros, with deliveries scheduled between 2027 and 2029. Announced in mid-December, this order caused a significant rebound in the stock. Financially, analysts hold contrasting views. Kepler Cheuvreux raised its price target from 33 to 47.20 euros on December 19, while changing its recommendation from Reduce to Hold, thus aligning its valuation closer to the current price. Conversely, JPMorgan maintains an overweight recommendation with a target at 60 euros, suggesting a potential upside of nearly 24%. This divergence of opinions illustrates the uncertainties surrounding the group's ability to convert its order book into sustainable operational results.
Nous sommes fiers de présenter notre performance sur les neuf premiers mois de l’année 2025, qui témoignent d'une croissance soutenue du chiffre d'affaires et de la marge brute ajustée, portée par la forte dynamique du secteur de la Défense.
Marché de la Défense très dynamique, forte demande pour la vision nocturne et les systèmes pour drones/anti-drones, croissance soutenue en Europe avec contribution des États-Unis et de l’Asie-Pacifique. Lancement commercial réussi des tubes 5G (plus de 5 000 commandes avant lancement).
Risks mentioned
Cession de l’activité Amplification par Micro-ondes entraînant une perte comptable sans impact de trésorerie en 2025
Dépendance aux budgets de Défense et aux évolutions géopolitiques
Risque d'intégration des acquisitions récentes
Incertitudes de la demande dans les Sciences de la Vie (marché américain)
Opportunities identified
Croissance adressable liée à la vision nocturne et aux applications drones/anti-drones
Commercialisation des tubes 5G avec commandes significatives (>5 000 tubes)
Expansion des capacités de production (+40% d’ici 2027) soutenant le développement commercial
Effets de croissance externe (Noxant, NVLS, Phasics) élargissant le marché adressable
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
